YOLFTbeta
Vetoquinol

Vetoquinol

0O1O · LSE

86.90EUR-1.30 (-1.47%)

Price History

Full chart

Market Stats

Previous Close88.20
Open87.10
Day Range86.90 – 87.10
52-Week Range66.30 – 89.98
Volume1
Market Cap947.47M
P/E (TTM)0.14
Forward P/E0.00
EPS5.32
Dividend Yield1.19%
Beta0.87
50-Day Avg102.37
200-Day Avg91.66

About

Vetoquinol SA, a veterinary pharmaceutical company, engages in designing, developing, and selling of veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA operates as a subsidiary of Soparfin SCA.

Company Details

Leadership

  • Mr. Matthieu FrechinCEO & Non-Independent Chairman of the Board · b. 1969
  • Mr. Dominique DerveauxChief Operations Officer & Group Deputy CEO · b. 1969
  • Mr. Alain MassonDeputy CEO & Pharmacist Manager · b. 1962
  • Mr. Regis Vimal du MonteilChief Financial Officer · b. 1965
  • Philippe GruetChief Scientific Officer
  • Sandrine PerrierChief Information Officer
  • Laurent ThoreDirector of Partnerships, Legal Affairs & Risks
  • Xavier BerthetDirector of Group Communications
  • Ms. Nathalie ArlecchiniGroup Human Resources Director

Financials

Income Statement

Currency: EUR2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue196.62M211.59M233.36M234.40M257.06M282.04M284.14M298.29M299.73M315.30M342.61M350.35M352.17M367.94M395.99M427.47M521.27M539.78M529.27M539.20M525.70M
Growth (%)-+7.62%+10.29%+0.44%+9.67%+9.72%+0.74%+4.98%+0.48%+5.20%+8.66%+2.26%+0.52%+4.48%+7.62%+7.95%+21.94%+3.55%-1.95%+1.88%-2.50%
Cost of Revenue68.76M72.91M129.85M76.25M86.17M158.86M163.86M154.44M149.96M154.84M169.00M217.92M242.68M253.35M282.97M303.49M353.90M367.41M237.89M380.25M365.33M
Gross Profit127.86M138.68M103.51M158.15M170.89M123.18M120.28M143.85M149.77M160.46M173.62M132.43M109.49M114.59M113.02M123.98M167.37M172.37M291.38M158.94M160.36M
Gross Margin65.03%65.54%44.36%67.47%66.48%43.67%42.33%48.22%49.97%50.89%50.67%37.80%31.09%31.14%28.54%29.00%32.11%31.93%55.05%29.48%30.50%
Operating Expense109.03M113.83M75.43M130.56M141.97M91.03M88.46M112.55M116.23M125.30M134.87M95.53M69.18M71.28M71.24M71.49M90.10M93.05M217.12M88.60M87.12M
Operating Income18.83M24.85M28.08M27.59M28.93M32.15M31.82M31.30M33.54M35.15M38.75M36.90M40.31M43.31M41.78M52.49M77.27M79.31M74.26M70.35M73.24M
Operating Margin9.58%11.75%12.03%11.77%11.25%11.40%11.20%10.49%11.19%11.15%11.31%10.53%11.45%11.77%10.55%12.28%14.82%14.69%14.03%13.05%13.93%
EBITDA26.68M33.26M38.55M37.80M36.48M43.33M45.28M39.08M44.41M47.39M51.31M50.04M51.90M57.27M58.79M59.29M116.86M108.44M99.18M109.38M105.47M
EBITDA Margin13.57%15.72%16.52%16.13%14.19%15.36%15.94%13.10%14.82%15.03%14.98%14.28%14.74%15.56%14.85%13.87%22.42%20.09%18.74%20.29%20.06%
Net Income12.44M15.82M18.64M18.56M18.21M22.25M22.70M22.57M23.58M25.77M24.16M27.83M34.83M36.26M28.59M19.22M62.86M47.99M55.56M58.69M57.30M
Net Income Margin6.33%7.48%7.99%7.92%7.08%7.89%7.99%7.57%7.87%8.17%7.05%7.94%9.89%9.85%7.22%4.50%12.06%8.89%10.50%10.88%10.90%
R&D------1.96M20.00M20.00M21.90M22.10M24.20M25.50M26.40M30.00M28.40M31.00M25.00M40.10M32.90M41.30M
R&D as % of Total Revenue------0.69%6.70%6.67%6.95%6.45%6.91%7.24%7.18%7.58%6.64%5.95%4.63%7.58%6.10%7.86%
Interest Expense2.07M2.08M4.51M2.94M3.97M2.75M862.00K692.00K579.00K601.00K672.00K594.00K496.00K354.00K983.00K1.08M1.04M3.26M1.14M1.24M1.25M
Interest Expense % of Total Revenue1.05%0.98%1.93%1.25%1.54%0.98%0.30%0.23%0.19%0.19%0.20%0.17%0.14%0.10%0.25%0.25%0.20%0.60%0.21%0.23%0.24%

Balance Sheet

Currency: EUR2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets199.72M210.62M228.41M236.43M283.67M309.45M318.31M356.44M351.83M419.36M412.48M439.17M443.97M465.58M511.47M646.09M624.56M651.85M692.23M744.13M763.63M
Total Liabilities112.90M99.47M100.53M99.38M128.72M125.18M107.02M128.43M115.88M150.97M122.98M122.21M108.13M102.50M125.49M274.26M183.21M167.19M165.12M168.20M172.19M
Total Equity86.80M111.12M127.84M137.03M154.92M184.24M211.25M227.97M235.91M268.34M289.44M316.42M335.66M363.10M386.35M371.75M441.26M484.57M527.01M575.84M591.37M
Cash26.98M21.72M40.34M25.84M1.55M55.83M57.77M81.59M83.93M90.81M87.07M103.30M74.08M117.63M84.51M129.44M69.00M93.71M147.46M206.33M221.08M
Total Debt50.97M42.49M-6.53M27.12M33.78M31.57M50.39M36.93M57.10M33.07M24.28M15.43M6.67M12.09M124.86M15.38M17.42M17.63M21.12M15.29M
Net Debt24.00M20.77M-40.34M-19.31M25.57M-22.04M-26.20M-81.59M-47.00M-33.71M-54.01M-79.02M-58.65M-110.96M-72.42M-4.58M-53.62M-76.29M-129.84M-185.21M-205.78M

Cash Flow

Currency: EUR2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow30.01M23.36M37.22M21.90M40.05M34.36M29.99M34.21M28.11M41.30M38.90M43.66M41.20M37.91M52.02M92.23M89.72M62.85M89.39M90.44M76.04M
Investing Cash Flow-9.10M-29.48M-8.67M-26.31M-35.15M-7.87M-21.13M-24.83M-7.69M-52.24M-15.26M-13.42M-15.68M-17.75M-64.55M-145.14M-33.45M-21.52M-18.88M-15.65M-20.56M
Financing Cash Flow-8.02M2.81M-6.55M-9.58M17.58M-25.76M1.02M1.56M-14.02M27.22M-23.01M-14.21M-14.54M-15.22M-20.12M101.99M-120.85M-16.06M-15.50M-20.64M-29.04M
Capital Expenditure10.47M25.54M8.44M8.87M7.67M7.76M9.62M7.53M6.47M10.24M11.02M13.60M13.71M14.22M9.45M10.34M13.82M16.97M14.90M14.55M17.02M
Free Cash Flow19.54M-2.18M28.78M13.04M32.38M26.60M20.37M26.68M21.63M31.06M27.88M30.07M27.50M23.69M42.58M81.89M75.89M45.88M74.50M75.89M59.02M
Dividends Paid1.63M5.83M2.59M3.02M3.02M3.26M3.55M3.91M4.14M4.38M4.63M4.86M5.10M5.46M5.68M4.49M5.91M9.46M9.46M10.06M10.40M
FCF to OCF65.10%-9.34%77.33%59.52%80.84%77.42%67.92%78.00%76.97%75.21%71.68%68.86%66.74%62.49%81.84%88.79%84.60%73.00%83.34%83.92%77.62%
Dividend Paid to FCF8.33%-267.05%9.01%23.20%9.33%12.24%17.41%14.64%19.13%14.11%16.60%16.16%18.54%23.03%13.34%5.49%7.79%20.63%12.71%13.25%17.62%

Earnings

Report DateSep 11, 2026Mar 25, 2027
EPS Estimate--
EPS Actual--
Surprise--
TimingAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap947.47M
Enterprise Value661.04M
Trailing P/E0.14
Forward P/E0.00
Price / Sales1.80
Price / Book0.00
EPS5.32
Book Value52.48
Revenue (TTM)527.34M
Gross Profit (TTM)311.69M
EBITDA107.26M
Profit Margin11.92%
Operating Margin15.11%
Return on Equity10.68%
Return on Assets7.04%
Shares Outstanding11.86M
Shares Float3.65M
Beta0.87
Dividend Yield1.19%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20261×
0.93Jun 3, 2026
20251×
0.89Jun 4, 2025
20241×
0.85Jun 4, 2024
20231×
0.80Jun 2, 2023
20221×
0.80Jun 1, 2022
20211×
0.50Jun 4, 2021
20201×
0.38Jun 2, 2020
20191×
0.48May 31, 2019
20181×
0.46Jun 4, 2018
20171×
0.43Jun 2, 2017
20161×
0.41Jun 2, 2016
20151×
0.39Jun 2, 2015
20141×
0.37Jun 2, 2014
20131×
0.35Jun 3, 2013